Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
Clinical trial NCT00246662 · COMPLETED
Trial details
- NCT number
- NCT00246662
- Sponsor
- Sunesis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-14
- Primary completion
- 2008-12-23
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.